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ABSTRACT Chikungunya virus (CHIKV) is a mosquito-borne alphavirus responsible
for several significant outbreaks of debilitating acute and chronic arthritis and ar-
thralgia over the past decade. These include a recent outbreak in the Caribbean is-
lands and the Americas that caused more than 1 million cases of viral arthralgia. De-
spite the major impact of CHIKV on global health, viral determinants that promote
CHIKV-induced disease are incompletely understood. Most CHIKV strains contain a
conserved opal stop codon at the end of the viral nsP3 gene. However, CHIKV
strains that encode an arginine codon in place of the opal stop codon have been
described, and deep-sequencing analysis of a CHIKV isolate from the Caribbean
identified both arginine and opal variants within this strain. Therefore, we hypothe-
sized that the introduction of the arginine mutation in place of the opal termination
codon may influence CHIKV virulence. We tested this by introducing the arginine
mutation into a well-characterized infectious clone of a CHIKV strain from Sri Lanka
and designated this virus Opal524R. This mutation did not impair viral replication ki-
netics in vitro or in vivo. Despite this, the Opal524R virus induced significantly less
swelling, inflammation, and damage within the feet and ankles of infected mice. Fur-
ther, we observed delayed induction of proinflammatory cytokines and chemokines,
as well as reduced CD4 T cell and NK cell recruitment compared to those in the
parental strain. Therefore, the opal termination codon plays an important role in
CHIKV pathogenesis, independently of effects on viral replication.
IMPORTANCE Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that
causes significant outbreaks of viral arthralgia. Studies with CHIKV and other alphavi-
ruses demonstrated that the opal termination codon within nsP3 is highly con-
served. However, some strains of CHIKV and other alphaviruses contain mutations in
the opal termination codon. These mutations alter the virulence of related alphavi-
ruses in mammalian and mosquito hosts. Here, we report that a clinical isolate of a
CHIKV strain from the recent outbreak in the Caribbean islands contains a mixture of
viruses encoding either the opal termination codon or an arginine mutation. Mutat-
ing the opal stop codon to an arginine residue attenuates CHIKV-induced disease in
a mouse model. Compared to infection with the opal-containing parental virus, in-
fection with the arginine mutant causes limited swelling and inflammation, as well
as dampened recruitment of immune mediators of pathology, including CD4 T
cells and NK cells. We propose that the opal termination codon plays an essential
role in the induction of severe CHIKV disease.
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Chikungunya virus (CHIKV) is a mosquito-borne alphavirus in the Togaviridae familythat is associated with large-scale outbreaks. Infection with CHIKV leads to a febrile
illness characterized by severe acute and chronic arthralgia. In 2005, CHIKV reemerged
during an outbreak on La Réunion Island off the coast of Africa. This epidemic affected
one-third of the island’s population and resulted in an estimated US $66.5 billion in
medical expenses (1). In 2013, locally acquired transmission of CHIKV was reported for
the first time in the Western Hemisphere on the island of St. Martin in the Caribbean.
This resulted in over 1 million suspected cases and 20,000 confirmed cases of CHIKV
infection throughout North, South, and Central America (2). Currently, there are no
vaccines or antivirals available to prevent or treat CHIKV infection.
The alphavirus genome is encompassed by a positive-sense single-stranded RNA of
approximately 11.7 kb (reviewed in reference 3). The nonstructural proteins (nsPs) are
encoded at the 5= end of the genome and translated as a polyprotein precursor that is
posttranslationally processed to produce the mature nsP1-4 proteins. During the initial
stages of infection, the major nonstructural protein species consist of the polyprotein
precursor nsP123 and nsP4. The latter is rapidly cleaved from the polyprotein and is
found solely in its mature state. A conserved opal stop codon is located within the C
terminus of the nsP3 gene in several alphaviruses (reviewed in reference 3). Read-
through of the opal stop codon during translation occurs infrequently and produces
full-length nsP1234. Consequently, stoichiometric concentrations of nsP4 are estimated
to be much lower than those of the other nonstructural proteins (4). The polyprotein
nsP123 and cleaved nsP4 mediate synthesis of the viral negative-sense RNA, which
serves as a template for genomic RNA production. Upon further cleavage into the
mature proteins nsP1, nsP2, nsP3, and nsP4, replication switches to replicate positive-
sense genomic RNA and transcribe subgenomic RNA. The structural polyprotein is
translated from subgenomic RNA and consists of capsid, E1, E2, E3, 6K, and transframe
(TF) (5, 6). Capsid is cleaved autocatalytically, and the structural proteins are further
processed in the endoplasmic reticulum (ER) (7, 8). Together, these proteins assemble
around genomic RNA and form virions at the plasma membrane.
Several studies have identified key viral determinants of alphavirus pathogenesis
within untranslated regions (UTRs), nonstructural proteins, and structural proteins
(9–12). Mutations within the viral nonstructural proteins and envelope glycoproteins
modulate type I interferon (13–16), host cell shutoff (17), and the stress response (18,
19). More recently, other work has explored the sequence diversity within clinical
isolates of CHIKV from the Caribbean outbreak. Through this analysis, a novel 3= UTR
sequence that allowed for enhanced replication in mosquito cells was discovered (20).
These data corroborate studies of both CHIKV and other alphaviruses that indicate that
mutations in the UTRs can have profound impacts on replication in mosquito vectors
(11, 12). However, studies on CHIKV-specific determinants of disease have been fairly
limited and have focused largely on host determinants that influence development of
severe disease (21, 22). Of those viral determinants that have been identified, a
mutation in the viral envelope (E1-A226V) played a major role in permitting CHIKV
replication within a novel mosquito vector, which allowed for an unprecedented
expansion of CHIKV into naive human populations (10). All together, these data provide
a strong rationale for identifying viral determinants of severe CHIKV disease.
Like many alphaviruses, the majority of CHIKV strains encode an opal termination
codon at the 3= end of nsP3 (20, 23, 24). However, some CHIKV isolates encode an
arginine residue in place of the opal termination codon, such as SGP007, a CHIKV isolate
from a patient in Singapore (25). Studies with Sindbis virus (SINV) have shown that the
opal stop codon regulates both the amount of nsP4 produced during infection (4) and
posttranslational cleavage of nsP34 (26). During translation of the nonstructural poly-
protein during the first few hours after infection, full-length nsP1234 comprises only 5
to 20% of the polyprotein products translated, while nsP123 is produced to much
greater abundance (4). Further, introduction of the arginine mutation into SINV results
in accumulation of uncleaved nsP34 instead of mature nsP3 (26). O’nyong-nyong virus
(ONN), a closely related alphavirus, encodes either an opal termination codon or an
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arginine codon (27, 28). One study demonstrated that the opal termination codon
confers a fitness advantage for ONN in Anopheles gambiae, its mosquito host (28).
However, infection with a SINV strain that naturally encodes a cysteine residue in place
of the opal stop codon leads to severe morbidity and mortality in mice (9). Together,
these data suggest that the presence of an amino acid residue in place of the opal stop
codon may alter CHIKV pathogenesis.
In this study, we examined a patient isolate of the Caribbean strain of CHIKV for
novel viral variants that could impact pathogenesis. We found that this strain of CHIKV,
which was isolated in St. Martin, encodes both the conserved opal termination codon
and the arginine mutation. Therefore, we tested how mutations in the opal stop codon
impact CHIKV replication and disease. To this end, we introduced the arginine mutation
into the infectious clone of a Sri Lankan strain of CHIKV that naturally encodes the opal
stop codon (29). The resulting virus was designated Opal524R. We found that the
presence of the arginine mutation did not significantly impact viral replication in
cultured cells or in target tissues in vivo, which is in contrast to prior findings with SINV
(26). Strikingly, the Opal524R mutant caused less-severe disease in a mouse model than
the wild-type virus, as measured by decreased swelling and histopathological damage
in the footpads and ankle joints of infected animals. The Opal524R mutant exhibited
delayed induction of proinflammatory cytokine and chemokine production and a
corresponding reduction of inflammatory leukocyte recruitment into the feet and ankle
joints. Therefore, these data indicate that the presence of an opal termination codon
within nsP3 has a major impact on CHIKV-induced disease severity.
RESULTS
Identification of the Opal524R mutation in the Caribbean strain of CHIKV. We
performed deep sequencing of a clinical isolate derived from a human patient from the
island of St. Martin obtained during the CHIKV outbreak in 2013 (GenBank accession no.
MG208125). Through this analysis, we identified a thymine-to-cytosine single nucleo-
tide polymorphism (SNP) within the opal termination codon resulting in a coding
change to an arginine residue (data not shown). This SNP was found in nearly 70% of
reads, making the arginine codon the dominant variant in this isolate. To examine the
role of the opal stop codon in CHIKV pathogenesis, we introduced an arginine codon
in place of the opal termination codon in an infectious clone of a Sri Lankan CHIKV
strain that is associated with severe disease in mouse models of CHIKV-induced arthritis
(29). The resulting mutant virus, which was designated Opal524R, was then character-
ized to test whether replacement of the opal termination codon had any impact on viral
replication or the pathogenesis of CHIKV-induced arthritis.
The Opal524R mutation does not adversely affect CHIKV replication. Mutations
in the opal termination codon and nearby sequence adversely impact multiple aspects
of replication in some SINV and CHIKV strains (4, 25, 26, 30). Therefore, we initially
tested whether the Opal524R mutation had any impact on viral replication in vitro. We
found no defects in Opal524R growth at high or low multiplicities of infection (MOI) in
Vero cells (Fig. 1A and B) or at a low MOI in Aedes albopictus C6/36 cells (Fig. 1D). In fact,
the Opal524R mutant showed enhanced replication compared to that of the wild-type
virus at early times postinfection in multistep growth curves (Fig. 1B), which is consis-
tent with prior findings for ONN (28). Furthermore, we found that the Opal524R mutant
produces genomic RNA with kinetics and abundances similar to those of the parental
virus (Fig. 1C). However, Vero cells exhibit impaired interferon signaling. Therefore, we
further tested the Opal524R mutant for replication defects in a human cell line with
intact innate immunity. When MRC-5 cells, which have a functional type I IFN response,
were infected at an MOI of 0.01, we found no defects in replication at early or late times
postinfection (Fig. 1E). These results indicate that the presence of the arginine residue
in place of the opal termination codon does not overtly impair CHIKV replication in
vitro.
The Opal524R mutation alters nsP4 processing. Previous reports indicated that
mutation of the opal stop codon to an amino acid in SINV can impact viral protein
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production or processing (26, 30). Therefore, we measured levels of nsP3 and E2 in Vero
cells infected with either the wild-type virus or the Opal524R mutant. Measurable levels
of mature nsP3 were observed beginning at 8 h postinfection for both viruses, although
levels were elevated for the Opal524R mutant compared to those of the wild-type virus
at this time point (Fig. 2A and B). However, the monoclonal antibody used in these
assays appears to be unable to detect nsP3 in the context of nsP123, nsP1234, or nsP34,
so we were unable to assess the efficiency of proteolytic cleavage of nsP3 from the
nonstructural polyprotein. Both the mature and immature isoforms of E2 were detect-
able at comparable levels for the two viruses, beginning at 8 h postinfection. We next
tested whether nsP4 production or processing was altered by the Opal524R mutation.
To measure different isoforms of nsP4, we generated CHIKV replicons with C-terminal
FLAG tags after nsP4 for both the wild-type and Opal524R viruses. BHK-21 cells were
electroporated with RNA from either replicon, and nsP4 production was measured
using antibodies against FLAG. The Opal524R mutant produced higher levels of mature
nsP4-FLAG beginning at 2 h postinfection and continuing through 8 h postinfection,
suggesting that the Opal524R mutation enhances translational read-through of the
nsP4 open reading frame (Fig. 2C and D). In addition, levels of immature nsP34-FLAG
were also higher for the Opal524R virus at all time points measured (Fig. 2C). Overall,
these results suggest that enhanced translational read-through by the Opal524R mu-
FIG 1 Mutation of the opal stop codon to an arginine does not impair CHIKV replication in vitro. (A, B) Vero cells
were infected in triplicate at a multiplicity of infection (MOI) of 5 (A) or 0.01 (B) with wild-type CHIKV (WT) or the
Opal524R mutant. The supernatant was collected from infected cells at the indicated times postinfection, and its
titer was determined by plaque assay on Vero cells. (C) Vero cells were infected in triplicate at an MOI of 5 as
described for panel A. At the indicated times postinfection, RNA was extracted for quantitative real-time RT-PCR.
(D, E) C6/36 cells (D) or MRC5 cells (E) were infected in triplicate at an MOI of 0.01 with wild-type CHIKV or the
Opal524R mutant. The supernatant was collected and its titer was determined as described for panels A and B.
Dashed lines represent the limit of detection for the assay. Data were analyzed by ANOVA for significance, with
corrections for multiple comparisons. All data are representative of two independent experiments. Statistical
significance is indicated as follows: *, P  0.05; **, P  0.01.
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tant results in increased levels of both the nsP34-FLAG precursor and mature nsP4-
FLAG within infected cells.
The Opal524R mutant fails to induce severe disease in a mouse model.We next
tested whether the Opal524R mutant exhibited altered virulence in vivo using a mouse
model of CHIKV-induced disease. In this model, footpad infection with wild-type CHIKV
results in biphasic footpad swelling and tenosynovitis within the inoculated foot (29).
The Opal524R mutant induced footpad swelling over that in mock-infected animals;
however, the level of swelling was significantly reduced compared to that caused by
the wild-type virus at both early and late times postinfection (Fig. 3A). This suggests
that the Opal524R mutant is less virulent in vivo than the parental virus in a mouse
model of disease.
Damage and inflammation is reduced in the ankle joints of Opal524R-infected
mice. To further analyze the impact of the arginine mutation on CHIKV-induced
disease, mock-infected or CHIKV-infected mice were sacrificed at 7 days postinfection
and inflammatory pathology was assessed within the feet and ankle joints on
hematoxylin-and-eosin-stained sections. We observed reduced inflammatory cell infil-
tration within the joints of mice infected with the Opal524R virus, consistent with the
attenuation in virus-induced swelling (Fig. 3B). Blind histological analysis also indicated
that infection with the Opal524R mutant resulted in less damage within ankle joints
and tendons (Fig. 3C). To more closely assess inflammation within joint tissues, we
stained for nitrotyrosine accumulation within the ankle joints at day 7 postinfection
(Fig. 3D). Under conditions of oxidative stress, superoxide and nitric oxide react to form
the free radical peroxynitrite, which causes nitration of tyrosine residues (31, 32).
Nitrotyrosine accumulation is a stable indicator of oxidative stress associated with
FIG 2 The Opal524R mutation alters levels of nsP34 and mature nsP4 within infected cells. (A, B) Vero cells were infected in duplicate
at a multiplicity of infection (MOI) of 5 with wild-type CHIKV or the Opal524R mutant. (A) At the indicated times postinfection (hours
postinfection [hpi]), protein was extracted for Western blotting. Blots were probed for the indicated markers. M, mock. (B) Densitometry
was performed for nsP3 and E2 using ImageJ software. Band intensity was normalized against that of actin, and the averages of intensities
in duplicate lanes from a representative blot are shown. Data are representative of two independent experiments. (C, D) CHIKV replicons
containing either the wild-type sequence or the Opal524R mutation were generated. Each replicon contains a C-terminal 3 FLAG tag
on nsP4 (nsP4-FLAG). BHK-21 cells were electroporated with 10 g of Sp6-transcribed RNA of the indicated replicon or mock
electroporated in 1 PBS. (C) At the indicated times postelectroporation (hours postelectroporation [hpe]), protein was extracted for
Western blotting. (D) Densitometry was performed for nsP3, nsP4-FLAG, and nsP34-FLAG using ImageJ software. Band intensity was
normalized against that of actin. Data are representative of two independent experiments.
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several inflammatory disease states, including celiac disease, rheumatoid arthritis, and
CHIKV infection (31–35). We previously found that wild-type CHIKV infection induces
oxidative stress within infected feet, as indicated by a pronounced accumulation of
nitrotyrosine within these tissues (36). Consistently with these earlier results, infection
with wild-type CHIKV resulted in high levels of nitrotyrosine staining in muscle, tendon,
and the synovial lining of the joints (Fig. 3D). However, we observed a marked decrease
in nitrotyrosine accumulation in all of these regions of the feet and ankle joints of mice
infected with the Opal524R mutant compared to that found in mice infected with the
parental virus. Together, these data support the conclusion that the opal termination
codon contributes to CHIKV-induced disease in vivo.
The Opal524R mutant replicates efficiently in vivo. Although the Opal524R
mutant replicated efficiently in vitro, one likely explanation for the differences in disease
induction between these two viruses might be a general defect in viral replication in
vivo. To address this, we measured replication within both proximal and distal tissues
at several times postinfection (Fig. 4). We found that the Opal524R mutant replicates
efficiently in all target tissues, including the ipsilateral and contralateral foot and
quadriceps muscles and popliteal lymph nodes. Levels of viremia in serum were also
equivalent between the two viruses. Therefore, while viral replication was transiently
FIG 3 The opal stop codon is required by CHIKV to induce severe disease. (A) Twenty-four-day-old C57BL/6J mice were either mock infected (n 6) or infected
with 100 PFU of wild-type CHIKV or the Opal524R mutant (9 to 10 mice per group) in the left rear footpad. Mice were monitored for 7 days, and footpad swelling
was measured in millimeters using calipers. (B, D) Mice from panel A were sacrificed at day 7 postinfection and perfused intracardially with paraformaldehyde.
Tissue sections were prepared from the ipsilateral foot and embedded in paraffin, and 5-m sections were prepared. Tissues were deparaffinized and stained
with either hematoxylin and eosin (B) or nitrotyrosine (D). Representative images of the ankles at a 10magnification are shown. (C) Hematoxylin-eosin sections
from panel B were scored blind for damage to the tendon and ankle joint. Horizontal lines indicate the arithmetic mean. B, bone; BM, bone marrow; J, joint
space; M, muscle; T, tendon; arrowhead, synovial lining. Data shown are from at least two independent experiments. Data were analyzed by ANOVA for
significance, with corrections for multiple comparisons. Statistical significance is indicated as follows: *, P  0.05, and **, P  0.01.
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reduced in the contralateral foot at day 3 postinfection (Fig. 4B), these results suggest
that the differences in virus-induced swelling and pathology in the inoculated foot
cannot be explained by differential in vivo replication. It is also possible that the
Opal524R virus may revert back to wild type in vivo, thereby leading to equivalent levels
of viral replication. To test this, subsets of mice (5 mice infected with the wild type; 7
mice infected with Opal524R) were sacrificed at 24 h postinfection and RNA was
extracted from the inoculated foot. Sequencing across the nsP3 gene confirmed that
the Opal524R mutation is stable and did not revert at 24 h postinfection in vivo.
Immune cell recruitment to the site of infection is limited during Opal524R
infection. Specific immune cell populations, including monocytes, CD4 T cells, and NK
(natural killer) cells, infiltrate the site of CHIKV infection in vivo and mediate disease (37,
38). Therefore, the differences in pathology that we observed might reflect differences
in levels of recruitment of specific immune cell mediators into the infected joints. We
tested this by measuring immune cell recruitment to the site of infection by flow
cytometry at day 7 postinfection. The prevalences of several types of immune cells
differed when mice were infected with the Opal524R mutant. Recruitment of CD4 T
cells and NK cells, two cell populations that contribute to CHIKV-induced inflammatory
pathology (37, 38), were reduced in Opal524R-infected mice (Fig. 5A). Overall numbers
of CD8 T cells and B cells were also reduced following Opal524R infection, despite the
fact that these cell populations have not been implicated as drivers of CHIKV-induced
inflammation (Fig. 5A). Interestingly, while monocytes have also been implicated in
driving CHIKV pathogenesis (38), we did not observe statistically significant differences
in levels of recruitment of monocytes between the Opal524R mutant (based on overall
cell numbers) and the wild type. In fact, we found that monocytes comprise a greater
percentage of total infiltrating leukocytes (defined as leukocyte common antigen-
positive [LCA] cells) during infection with the Opal524R virus than during infection
with the wild type (Fig. 5B). Overall, these data suggest that attenuation of swelling
FIG 4 CHIKV replication at target sites in vivo is not impaired by mutagenesis of the opal stop codon. Twenty-four-day-old C57BL/6J mice
were infected in the left rear footpad with 100 PFU of wild-type CHIKV or the Opal524R mutant (9 to 10 mice per group per time point).
Mice were sacrificed at 1 (A), 3 (B), 5 (C), or 7 (D) days postinfection, and the indicated tissues were harvested. Tissues were homogenized
and titers were determined by plaque assay on Vero cells. Horizontal bars represent the arithmetic mean. Dashed horizontal lines
represent the limit of detection for the assay. LF, left (ipsilateral) foot; LQ, left quadriceps muscle; RF, right (contralateral) foot; RQ, right
quadriceps muscle; LN, popliteal lymph node. Combined data from two independent experiments are shown. Data were analyzed by
one-way ANOVA for significance, with corrections for multiple comparisons. Statistical significance is indicated as follows: *, P  0.05.
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during Opal524R infection may be due in part to a failure to recruit high levels of CD4
T cells and NK cells but cannot be explained by differences in monocyte recruitment.
Proinflammatory cytokines and chemokines are produced to lower levels at
day 1 postinfection. Persistent arthralgia in CHIKV-infected patients is characterized by
high levels of certain proinflammatory cytokines, such as interleukin 6 (IL-6), MIG
(monokine induced by interferon gamma), and IP-10 (interferon gamma-induced pro-
tein 10) (39, 40). Based on the differences described in inflammatory cell recruitment,
we hypothesized that differential chemokine activation during Opal524R infection
accounts for the lower numbers of CD4 T cells and NK cells recruited to the site of
infection. To address this question, we measured cytokine production within the
ipsilateral foot early during infection. Infection with wild-type CHIKV induced produc-
tion of several cytokines at day 1 postinfection, including the proinflammatory cyto-
kines tumor necrosis factor alpha (TNF-), IL12p70, and the chemokines CXCL9 (CXC-
motif chemokine 9) (MIG), CXCL10 (IP-10), CCL3 (CC-motif chemokine 3) (MIP-1), CCL4
(MIP-1), CCL5 (RANTES), and CCL7 (MCP3) (Fig. 6A). Protein levels for all of these
cytokines were significantly reduced during Opal524R infection. Of these, CXCL9 (MIG),
CXCL10 (IP-10), and CCL4 (MIP-1) are known T cell and NK cell chemoattractants.
Further, although we did not observe significant differences in monocyte recruitment
to the footpad, CCL3, CCL4, CCL7, and CXCL10 are all known monocyte chemoattrac-
tants that were also significantly reduced during Opal524R infection. This difference in
early chemokine production is consistent with our findings that CD4 T cells, CD8 T
cells, and NK cells are less efficiently recruited during Opal524R infection.
Levels of cytokine production are comparable between the wild type and
Opal524R at day 2 postinfection. At day 2 postinfection, many of the cytokines
induced by wild-type infection were induced to comparable levels by Opal524R infec-
tion, with two exceptions. TNF- and CCL4 (MIP-1) continued to be produced to
significantly lower levels during Opal524R infection (Fig. 6B). Wild-type infection also
induced IL-6, CCL2 (MCP-1), and CXCL1 at day 2 postinfection and suppressed IL-15
production compared to levels in mock-infected animals. By comparison, CCL2 and IL-6
were significantly reduced during Opal524R infection at day 2 postinfection. Together,
these data suggest that there is a delay in activation of many proinflammatory
cytokines early during Opal524R infection. Notably, TNF- and CCL4 levels were
significantly lower during Opal524R infection at days 1 and 2 postinfection (Fig. 6).
These differences may account for the reduction in inflammatory cell infiltration and
pathology observed in the joint during infection with the Opal524R mutant.
Cytokine induction is also diminished at the transcript level. We further con-
firmed differences in cytokine production by measuring mRNA transcript levels for a
subset of cytokines by quantitative real-time reverse transcription PCR (qRT-PCR). In
FIG 5 Failure of the CHIKV Opal524R mutant to induce severe disease is associated with low immune cell
infiltration. (A, B) C57BL/6J mice were infected at 24 days old in the left rear footpad with 100 PFU of wild-type
CHIKV or the Opal524R mutant or mock infected with diluent (6 per group). At 7 days postinfection, mice were
sacrificed and perfused intracardially with 1 PBS. The ipsilateral foot was harvested and processed for analysis by
flow cytometry. Recruitment of the indicated inflammatory leukocyte populations was measured and expressed as
either total cell counts per foot (A) or percentage of LCA cells (B). Data are representative of two independent
experiments. Individual data points, which are represented by a solid dot, represent outliers. These are defined as
values that exceed the third quartile plus 1.5 times the interquartile range (IQR) or fall below the first quartile minus
1.5 times the IQR. Statistical significance is indicated as follows: *, P  0.05, and **, P  0.01.
Jones et al. ®
November/December 2017 Volume 8 Issue 6 e01456-17 mbio.asm.org 8
mice infected with wild-type virus, transcripts were only modestly elevated at day 1
postinfection for CCL2, CCL4, IL-6, and CXCL9, while CXCL10 transcripts were very
highly elevated relative to levels in mock-infected mice (Fig. 7A). Consistently with the
reduction in protein levels observed, CCL4 and CXCL10 transcripts were significantly
reduced in Opal524R-infected mice relative to those in wild-type-infected mice. TNF-
mRNA levels were not significantly different from those in mock-infected mice for either
virus. At day 2 postinfection, both TNF- and IL-6 transcripts were moderately induced
by wild-type virus, while CCL2, CCL4, CXCL9, and CXCL10 mRNA levels were all highly
elevated by wild-type virus infection (Fig. 7B). There was a significant reduction in
TNF-, IL-6, and CXCL10 transcripts during Opal524R infection at this time point. These
data support the conclusion that the Opal524R mutant differentially induces proin-
flammatory cytokines and chemokines.
DISCUSSION
There is presently no consensus on the requirement for the opal termination codon
in alphavirus replication. The AR86 strain of SINV and the SFV4 and prototype strains of
Semliki Forest virus (SFV) tolerate coding changes in place of the opal termination
FIG 6 The opal termination codon enhances CHIKV-mediated induction of proinflammatory cytokine and chemokine
production. (A, B) C57BL/6J mice were infected at 24 days old in the left rear footpad with 100 PFU of wild-type CHIKV (n
5) or the Opal524R mutant (n  5) or mock infected with diluent (n  3). At days 1 (A) and 2 (B) postinfection, mice were
sacrificed and perfused intracardially with 1 PBS, and the ipsilateral foot was harvested and homogenized in PBS.
Cytokine production was measured in tissue homogenates by multiplex ELISA. Data were analyzed by the Mann-Whitney
U test. Asterisks indicate significance after multiple comparisons were corrected with the Benjamini-Hochberg method,
using a false-discovery rate of 0.1.
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codon (9, 41), and these mutations can enhance virulence. Furthermore, ONN replica-
tion in vitro is actually enhanced by introduction of an arginine codon in place of the
opal stop codon (28). Conversely, mutations to the opal termination codon and nearby
sequence adversely impact multiple aspects of replication in other SINV strains (4, 26,
30). Specifically, translational read-through of the opal codon, proteolytic cleavage of
nsP34, production of genomic RNA, and production of infectious particles in vitro are all
negatively impacted when the opal termination codon or the cytosine base immedi-
ately downstream are mutated. Similarly, another study found that nonisogenic CHIKV
strains encoding the opal stop codon replicate more efficiently in vitro than arginine-
containing strains (25).
In this study, we identified a mutation of the opal termination codon to an arginine
residue in a patient-derived isolate of CHIKV from the recent Caribbean outbreak,
isolated on St. Martin. One other CHIKV sequence available from a patient on St. Martin
also contains the Opal524R mutation (GenBank accession number KX262991). However,
sequences from patient isolates from other regions of the Caribbean outbreak contain
the opal stop codon. Specifically, 10 isolates analyzed from Haiti (GenBank accession
numbers KX702401.1, KX702402, and KY415978 to KY415985) and 15 isolates analyzed
from Puerto Rico (GenBank accession numbers MF001505 to MF001519) all contain the
opal stop codon (42). This may suggest that early isolates of CHIKV from the Caribbean
outbreak contained the Opal524R mutation but that this was lost over time. Further
sequence analysis of more patient samples from different stages of the outbreak will be
required to ascertain whether this occurred.
Earlier work demonstrated that the Opal524R mutation can be tolerated in isolates
of CHIKV from other regions (e.g., SGP007, a patient isolate from Singapore) but that the
SGP007 isolate exhibited reduced replication efficiency relative to those of other CHIKV
isolates (SGP011, another patient isolate from Singapore, and IMT, a La Réunion strain)
(25). Our study instead demonstrates that the Opal524R mutation can be efficiently
tolerated in the context of CHIKV with no cost to overall replication efficiency. However,
there are important differences between these studies that might account for these
discrepancies. Our study utilized virus stocks derived from infectious clones, so only the
effect of the Opal524R mutation was considered. In contrast, these earlier comparative
FIG 7 Cytokine gene expression is reduced during CHIKV Opal524R infection. (A, B) Twenty-four-day-old C57BL6/J mice were
infected in the left rear footpad with 100 PFU of wild-type CHIKV (n  5) or Opal524R (n  5) or mock infected with diluent
(n  3). At days 1 (A) and 2 (B) postinfection, mice were sacrificed and perfused intracardially with 1 PBS, and the ipsilateral
foot was harvested in TRIzol. RNA was extracted, cDNA was generated, and cytokine gene expression was assessed by
quantitative real-time PCR. Each cytokine was normalized to host 18S gene expression. Fold changes in gene expression
relative to mock infection (left) and wild-type infection (right) are shown. Data are representative of two independent
experiments. Statistical significance is indicated as follows: *, P  0.05, and **, P  0.01.
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analyses were based on patient isolates. In particular, the SGP007 strain contains six
additional coding changes from the sequences of IMT and SGP011 that may interact
with the Opal524R mutation to contribute to the observed replication defects. To-
gether, these reports may suggest that additional linked mutations are required for
optimal replication efficiency. Further investigation of such potential linked mutations
is under way.
This study demonstrates that the conserved opal termination codon within CHIKV is
required for induction of severe disease in a mouse model of CHIKV-induced arthritis.
Mutations to the opal stop codon enhance virulence in the AR86 strain of SINV (9) and
in the SFV4 strain of Semliki Forest virus (41), but the data reported herein instead
suggest that the arginine mutation found in CHIKV does not increase disease severity
or replication in a mouse model of disease. These results illustrate that mutations to the
opal stop codon may have contrasting effects on the virulences of different alphavirus
family members, while also raising the possibility that such mutations may impact other
aspects of the CHIKV replication cycle. Furthermore, understanding how the opal
termination codon modulates alphavirus virulence and the mechanisms underlying this
effect may have important implications for the development of live attenuated vaccines
against viruses such as CHIKV. As such, additional studies of the molecular mechanism
by which the opal stop codon contributes to CHIKV virulence are warranted.
In this study, we demonstrate that the opal termination codon plays an important
role in CHIKV pathogenesis. We observed striking differences between the Opal524R
mutant and the parental virus in both immune pathology and tissue inflammation.
However, these effects occur independently of any measurable effect on viral replica-
tion. Our results do suggest that the Opal524R mutation alters translational read-
through of nsP4, resulting in increased expression of both mature nsP4 and the nsP34
cleavage intermediate within infected cells. Further studies are necessary to discern
whether these differences in nonstructural protein processing can account for differ-
ential disease outcomes. For example, although we did not observe differences in
genomic RNA expression in infected cells (Fig. 1C) or altered viral replication in
IFN-competent cells (Fig. 1E) or in vivo (Fig. 4), we cannot rule out the possibility that
increased levels of nsP4 expression alter viral RNA synthesis. These differences may
enhance innate immune sensing or cellular stress responses, thereby boosting the early
immune response and limiting pathological downstream immune responses. Addi-
tional studies to test these possibilities are underway.
While we did not see any negative impact of the Opal524R mutation on replication
in an Aedes albopictus cell line, C6/36, we cannot rule out the possibility that this
mutation will impact other aspects of the viral replication cycle in mosquito vectors. As
noted above, studies with the closely related alphavirus ONN have identified the
presence of both opal and arginine codons in nsP3 (27, 28). ONN strains carrying the
arginine codon exhibited a growth advantage in vitro, which is similar to our findings
with CHIKV (Fig. 1). However, these studies demonstrated that the opal termination
codon enhanced infection in the mosquito vector, which may explain why the vast
majority of CHIKV isolates sequenced to date encode the opal termination codon,
rather than arginine, at nsP3 position 524. Therefore, additional studies are clearly
needed to directly test the potential role of the opal termination codon in CHIKV
replication in mosquito vectors.
Currently, there are no effective vaccines available to protect against CHIKV-induced
disease. In this study, we show that mutation of the opal stop codon produces a viable
mutant that fails to induce severe disease. CHIKV infection in human patients is
characterized by induction of several proinflammatory cytokine and chemokine mark-
ers, including gamma interferon (IFN-), TNF-, IP-10, and IL-6 (39, 40, 43). Our group
and others have demonstrated that similarly high production of these and other
cytokines occur very early during CHIKV infection in a mouse model (38–40). These
cytokines are induced more slowly during infection with the Opal524R mutant. There-
fore, inclusion of opal stop codon mutations within live attenuated CHIKV vaccines
containing other attenuating mutations may represent a reasonable strategy to gen-
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erate a protective immune response. However, additional studies are needed to assess
both the safety and the stability of such live attenuated viruses.
In addition to their potential for application in vaccine design, our results may have
implications for the development of CHIKV therapeutics. A recent study by Ashbrook et
al. found that inhibitors of sodium-potassium ATPases antagonize CHIKV replication
and that drug-resistant variants often contain mutations in the opal termination codon
(44). Drug-resistant variants containing the Opal524R mutation were also obtained
when CHIKV was instead passaged in the presence of difluoromethylornithine (DFMO),
a drug that inhibits polyamine biosynthesis and thereby restricts viral replication (45,
46). Interestingly, the Opal524R mutant did not replicate as well as the parental strain
in either Aedes albopictus mosquitos or zebrafish, but when combined with additional
drug-resistant mutations, the Opal524R mutation enhances replication in vivo (46).
Although these drug-resistant variants have not, to our knowledge, been tested for
virulence in a mouse model, our results suggest that these viruses would cause less
tissue damage than the parental virus. Therefore, antiviral therapies that result in
coding changes to the CHIKV opal stop codon may have the added benefit of selection
for less virulent variants.
In summary, our results demonstrate that the opal termination codon plays an
essential role in promoting the development of CHIKV-induced arthritis independently
of effects on viral replication. Most CHIKV isolates sequenced to date contain opal
termination codons at nsP3 position 524; however, we observed no negative impact of
the arginine mutation on viral replication. Taken together, these results suggest that
the opal termination codon plays an essential role in regulating multiple aspects of the
CHIKV replication cycle while also promoting CHIKV-induced inflammatory pathology.
MATERIALS AND METHODS
Viruses and cells. All infectious work with CHIKV was performed under biological safety level 3
conditions using approved standard operating procedures. The clinical isolate of the Caribbean strain of
CHIKV used in this study (GenBank accession no. MG208125) was provided by Michael Diamond
(Washington University) and was amplified three times in Vero cells prior to receipt by our lab. This
isolate was originally obtained from a human patient on the island of St. Martin during the 2013 outbreak
and acquired from the World Reference Center for Emerging Viruses and Arboviruses (University of Texas
Medical Branch). Virus stocks were amplified in the Aedes albopictus C6/36 cell line. The parental strain
of CHIKV used in this study was generated from the clinical isolate SL15649, which originated in Sri Lanka
(29). The infectious clone pMH56.2 encodes the full-length genome of this isolate and has been
previously described (36). An infectious clone for the mutant virus Opal524R was generated through
site-directed mutagenesis. Specifically, primer sets encoding the Opal524R mutation (forward, 5=GAGA
AGCCCGGGACGCAGAAAAAG; reverse, 5=GACCTGGACCGGTGTCCGACGAGAATATATACCCACCTGCCCTGT
CTAGTCGTAACTC) were used. This amplicon was ligated into the pMH56.2 plasmid backbone. The entire
ligated region of the purified, clonal plasmid was sequenced to confirm that no spurious mutations were
introduced. Virus stocks from both the wild-type and Opal524R mutant CHIKV strains were produced
from electroporation of in vitro-transcribed RNA of each infectious clone (mMessage mMachine SP6
transcription kit; Life Technologies, Inc.) into baby hamster kidney (BHK-21) cells (ATCC CCL-10). African
green monkey Vero cells (ATCC CCL-81), human lung fibroblast MRC-5 cells (ATCC CCL-171), and
A. albopictus C6/36 cells (ATCC CRL-1660) were used to obtain growth curves. Vero cells were used to
perform all plaque assays.
Mice. All mice used in this study were C57BL/6J mice purchased from the Jackson Laboratory and
bred in house. Twenty-four-day-old mice were inoculated subcutaneously in the left rear footpad with
100 PFU of CHIKV in phosphate-buffered saline (PBS) supplemented with 1% fetal bovine serum (FBS).
Mock-infected mice were inoculated with diluent alone. Mice were weighed daily and monitored for
clinical signs of disease. Footpad swelling was measured using calipers. Mouse sacrifice was performed
using isoflurane (Attane; Minrad, Inc.) overdose. Animal husbandry and experiments were conducted
under biosafety level 3 conditions and followed approved guidelines set forth by the University of North
Carolina at Chapel Hill Institutional Animal Care and Use Committee.
Sequencing of a CHIKV isolate. The Caribbean isolate of CHIKV used in this study was amplified
once on C6/36 cells. At 30 h postinfection, supernatants were collected and virus was purified on a 20%
sucrose gradient by ultracentrifugation at 24,000  g at 4°C overnight. Purified virus was resuspended
in 1 PBS. RNA was isolated from purified virus preparations by TRIzol extraction (Ambion). Random
priming was performed by annealing random primer 9 (New England Biolabs) to total RNA samples.
cDNA was reverse transcribed using SuperScript II (Thermo, Fisher Scientific). Double-stranded DNA
(dsDNA) was then produced by use of NEBNext mRNA second-strand synthesis module (New England
Biolabs), and dsDNA was purified using a PureLink PCR microkit (Thermo, Fisher Scientific) according to
standard procedures. Libraries were created using a Nextera XT DNA library preparation kit and
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sequenced on a MiSeq desktop sequencer using MiSeq reagent kit v2 (300 cycles) (Illumina). Coverage
of the site analyzed included 35,377 reads.
Growth curves. Vero and C6/36 cells were infected in complete medium in triplicate at the indicated
multiplicities of infection at 37°C or 28°C, respectively. At 1 h postinfection, inoculum was removed and
cells were rinsed three times with PBS. Medium was replenished, and cells were incubated at 37°C or
28°C. At the times postinfection indicated in the figures, the supernatant was collected and stored at
80°C and medium was replenished to maintain a total volume of 1 ml per well.
Virus titers. The titers of all virus stocks, cellular supernatants, and tissue homogenates were
determined by standard plaque assay on Vero cells. At the times postinfection indicated in the figures,
mice were sacrificed by isoflurane overdose and perfused via intracardial injection with 1 PBS. Tissues
designated for titration were harvested in 1 PBS and homogenized. All samples were stored at 80°C
until the time of plaque assay.
Sequencing of the Opal524R mutation in infected tissues. Mice were sacrificed at 24 h postin-
fection, and the inoculated foot was removed. RNA was extracted from tissues using TRIzol (Ambion).
Tissues were dissociated by homogenization prior to RNA extraction. Superscript III reverse transcriptase
(Invitrogen) was used to generate cDNA by random priming from a total of 10 g RNA from each sample.
PCR was performed using Phusion polymerase (New England Biolabs) with primers flanking the opal stop
codon to generate short amplicons (1 PCR per mouse; 5 mice for wild-type infections and 7 mice for
Opal524R infections) that were analyzed by standard Sanger sequencing.
Detection of nsP4. A replicon plasmid that contains the pMH56.2 backbone encoding GFP in place
of the structural genes was used. The Opal524R mutation was introduced into the replicon by restriction
digestion of the Opal524R infectious clone and ligation into the replicon plasmid. A 3 FLAG tag was
cloned at the C terminus of nsP4 in a two-step fusion PCR using the following primer sets: 5=CGGACA
CCGGTCCAGGTCATTTAC (forward), 5=CTACTTGTCATCGTCATCCTTGTAATCGATGTCATGATCTTTATAATCAC
CGTCAGGTCTTTGTAGTCTTTAGGACCGCCGTACAAAGTTATG (reverse 1), and 5=CACCATGGCGCGCCTGTAG
CTGATTAGTGTTTAGATACTTGCTGTCGGCTTCTGCAAAATAGGTAGCTGTAGTGCGTACCTACTTGTCATCGTC
ATCCT (reverse 2). All constructs were sequenced across the opal stop codon and FLAG tag to confirm
that no spurious mutations were introduced. RNA was in vitro transcribed from linearized plasmids
(mMessage mMachine SP6 transcription kit; Life Technologies, Inc.) and purified by lithium chloride
extraction. For each replicon, a total of 10 g RNA was electroporated into BHK-21 cells.
Western blotting. Cells were rinsed in PBS, lysed in radioimmunoprecipitation assay (RIPA)
buffer, and heated at 95°C for 5 min to ensure inactivation of infectious material. Lysates were
clarified by centrifugation at 15,000  g for 10 min, and protein was quantified by Bradford assay.
Loading dye was added to equal quantities of protein from each sample, and these were resolved
on SDS-PAGE gels. Protein was transferred onto polyvinylidene difluoride (PVDF) membranes,
blocked for 1 h in 5 or 10% milk in Tris-buffered saline with Tween 20 (TBS-T), and probed overnight
with the following antibodies: CHIKV nsP3 (mouse monoclonal, 1:500; produced in collaboration
with Mary Ann Accavitti-Loper, University of Alabama Birmingham), CHIKV E2 (mouse monoclonal,
1:1,000; provided by Michael Diamond, Washington University), FLAG M2 (mouse monoclonal,
1:1,000; Sigma-Aldrich), and actin (goat monoclonal, 1:1,000; Santa Cruz Biotechnology). Secondary
antibodies conjugated to horseradish peroxidase (HRP) were used against mouse (GE Healthcare)
and goat (Sigma) primary antibodies.
Densitometry analyses. Bands were quantified for mature E2, nsP3, nsP34, or nsP4, where indicated,
using ImageJ software (National Institutes of Health; version 1.48). Band densities were normalized to
internal lane background densities. Band densities for individual viral proteins were then normalized to
actin levels. Where indicated, band densities for duplicate lanes of an individual experiment were
averaged.
Histological analyses. Mice were sacrificed and perfused intracardially with 4% paraformaldehyde.
Tissues were embedded in paraffin, and 5-m sections were prepared. Tissues were stained with
hematoxylin and eosin. Slides were deidentified and scored for inflammation and musculoskeletal tissue
damage as described previously (36). Slides were imaged using an Olympus BX43 model microscope with
CellSens software.
Immunohistochemistry. Immunohistochemical analysis of nitrotyrosine levels has been described
previously (36). Briefly, tissues were fixed in 4% paraformaldehyde and embedded in paraffin, and 5-m
sections were prepared. Slides were deparaffinized with xylene, blocked in 10% donkey serum (Jackson
ImmunoResearch), and stained with antibody for nitrotyrosine (Millipore). Biotinylated secondary anti-
bodies were detected with streptavidin–DyLight-594 conjugate, and slides were mounted with ProLong
antifade reagent gold (Invitrogen). Slides were imaged with an Olympus BX60 fluorescence microscope;
images were collected with the iVision v.4.0.0 software (BioVision Technologies).
Flow cytometry. Mice were sacrificed and perfused with 1 PBS, and the ipsilateral foot was
harvested in digestion medium (complete RPMI medium supplemented with collagenase A and DNase).
Spleen was harvested from mock-infected mice in 1 PBS and used for control stains. All tissues were
minced, and feet were further dissociated by shaking them for 1.5 to 2 h at 37°C. Tissues were then
rinsed, lysed in ACK (ammonium chloride potassium) buffer, rinsed again, and plated in HFA (Hanks’
balanced salt solution [HBSS] supplemented with 1% FBS and 1% sodium azide). Tissues were stained for
30 min at 4°C with the following antibodies: fluorescein isothiocyanate (FITC)-anti F4/80 (EBioscience),
phycoerythrin (PE)-anti CD115 (EBioscience), PETR (Texas Red with R-phycoerythrin)-anti CD11c (Invitro-
gen), peridinin chlorophyll protein (PerCP)-Cy5.5-anti Ly6C (BioLegend), PE-Cy7-anti LCA (EBioscience),
eF450-anti CD11b (EBioscience), allophycocyanin (APC)-anti GR-1 (BioLegend), APCeF780-anti major
histocompatibility complex class IIc (MHC-IIc) (EBioscience), FITC-anti CD3e (EBioscience), PE-anti NK1.1
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(EBioscience), PETR-anti CD4 (Invitrogen), PerCP-anti CD8 (BD), PE-Cy7-anti LCA (EBioscience), and
APC-anti B220 (EBioscience). Flow cytometry was performed on a Beckman Coulter, Inc., CyAn advanced
digital processor (ADP) and analyzed using Summit software. Neutrophils were classified as either LCA
CD11c or LCA CD11c Gr1. Monocytes were classified as LCA CD11c CD11b. T cells were
classified as LCA CD3e and either CD4 or CD8. B cells were classified as LCA CD3e B220. NK cells
were classified as LCA CD3e NK1.1.
Quantitative real-time PCR. Mice were sacrificed and perfused intracardially with 1 PBS. RNA
was extracted from cells and tissues using TRIzol (Ambion). Tissues were dissociated by homoge-
nization prior to RNA extraction. Superscript III reverse transcriptase (Invitrogen) was used to
generate cDNA by random priming from a total of 10 g RNA from each sample. Real-time PCR was
performed using ABI Prism 7300 sequence detection system software (v1.4.0) and TaqMan Gene
Expression master mix (Applied Biosystems). For absolute quantification of viral RNA, CHIKV
sequence-specific primer probes were used as described previously (29). A standard curve was run
in tandem using CHIKV plasmid. For quantification of host transcripts, relative quantification was
performed using the ΔΔCT method (where CT is threshold cycle). For all PCR targets, quantification
was normalized to the amount of 18S rRNA present in the sample. Absolute quantification of 18S was
performed using a standard curve.
Cytokine and chemokine protein quantification. Protein levels of cytokines/chemokines in
clarified tissue homogenates were evaluated using a multiplex bead array assay. All the antibodies
and cytokine standards were purchased as antibody pairs from R&D Systems or PeproTech. Indi-
vidual magnetic bead regions (Luminex Corp.) were coupled to cytokine-specific capture antibodies
according to the manufacturer’s recommendations. Conjugated beads were washed and kept at 4°C
until use. Biotinylated polyclonal antibodies were used at twice the concentrations recommended
for a classical enzyme-linked immunosorbent assay (ELISA) according to the manufacturer. All assay
procedures were performed in assay buffer containing PBS supplemented with 1% normal mouse
serum (Invitrogen), 1% normal goat serum (Invitrogen), and 20 mM Tris-HCl (pH 7.4). The assays were
run using 1,500 beads per each set of cytokines measured per well in a total volume of 50 l. A total
of 50 l of each sample was added to the well and incubated overnight at 4°C. After being washed,
the beads were resuspended in 50 l of assay buffer containing biotinylated polyclonal antibodies
against the measured cytokines for 1 h at room temperature, washed again, and then resuspended
in 50 l of assay buffer containing 1 g/ml solution of streptavidin-PE (Invitrogen). The plates were
read on a Luminex MAGPIX platform. For each bead set, 50 beads were collected. The median
fluorescence intensity of these beads was recorded and used for analysis with the Milliplex software
using a 5P regression algorithm.
Statistical analyses. All data were analyzed in the statistical programing language R (v.3.0.2). Where
indicated in the figures, analysis of variance (ANOVA) was used to determine statistical differences
between data sets; Tukey’s honestly significant differences method was used post hoc to correct for
multiple comparisons. Where applicable, * indicates a P value of less than 0.05 and ** indicates a P value
of less than 0.01. Multiplex array data were analyzed by a nonparametric Mann-Whitney U test. The
false-discovery rate was set to 0.1, and significance was determined using the Benjamini-Hochberg
method for multiple-comparison corrections. Where applicable, * indicates significance under these
criteria.
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